ID NOW RSV 435-000Recalls & reported problems
Alere Scarborough, Inc. · A rapid, automated, molecular test for the qualitative detection of respiratory syncytial virus (RSV) nucleic acid in nasopharyngeal specimens. · Class 2
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
2 FDA recall records name this device's identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Mar 4, 2025Open, Classified
the impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Z-1576-2025 · Root cause: Process change control · FDA record ↗
- Mar 4, 2025Open, Classified
The impacted lots have a higher occurrence of invalid rates when compared to the product Instructions for Use.
Z-1573-2025 · Root cause: Process change control · FDA record ↗
Other Respiratory Virus Panel Nucleic Acid Assay System devices
- Simplexa™ Flu A/B & RSV Direct Gen II MOL2655Diasorin Molecular LLC · Respiratory Virus Panel Nucleic Acid Assay System1 recall0 reports
- Panther Fusion® AMR KIT, PANTHER FUSION, 96T, IVDHologic, Inc. · Respiratory virus panel nucleic acid assay system2 reports
- Alere™ i Influenza A & B 425-024Alere Scarborough, Inc. · Respiratory Virus Panel Nucleic Acid Assay System1 death1 report
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.